These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13882446)

  • 41. Kallikrein-like activity in the urine of renal hypertensive rats.
    Croxatto HR; San Martin M
    Experientia; 1970 Nov; 26(11):1216-7. PubMed ID: 5530289
    [No Abstract]   [Full Text] [Related]  

  • 42. [Uterotonic action of synthetic bradykinin in the pregnant woman at term].
    SICUTERI F; CENTARO A; MASSI GB; PERITI P
    Boll Soc Ital Biol Sper; 1962 Jul; 38():665-7. PubMed ID: 13912513
    [No Abstract]   [Full Text] [Related]  

  • 43. [Data on the biological substrate for the determination of plasma bradykininogen and urinary bradykinin in man].
    PERITI P; SICUTERI F
    Boll Soc Ital Biol Sper; 1962 Apr; 38():316-20. PubMed ID: 14485360
    [No Abstract]   [Full Text] [Related]  

  • 44. Visceral pain and the pseudaffective response to intra-arterial injection of bradykinin and other algesic agents.
    GUZMAN F; BRAUN C; LIM RK
    Arch Int Pharmacodyn Ther; 1962 Apr; 136():353-84. PubMed ID: 13903244
    [No Abstract]   [Full Text] [Related]  

  • 45. Alteration by kallikrein and bradykinin of the conversion of angiotensin I to angiotensin II in the isolated perfused rat lung.
    Ercan ZS; Bor NM; Torunoğlu M; Türker RK
    Arzneimittelforschung; 1982; 32(1):30-1. PubMed ID: 6174131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Participation of the kallikrein-kinin-receptor system in reflexes arising from neural afferents in the dog epicardium.
    Staszewska-Woolley J; Woolley G
    J Physiol; 1989 Dec; 419():33-44. PubMed ID: 2576069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats.
    Uehara Y; Hirawa N; Numabe A; Kawabata Y; Ikeda T; Gomi T; Gotoh A; Omata M
    Am J Hypertens; 1997 May; 10(5 Pt 2):83S-88S. PubMed ID: 9160787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of activators and inhibitors of the kallikrein-kinin system on adrenergic responses of the heart and vessels].
    Rzaev NM; Abaskulieva LI; Khanumova TA; Akhverdiev TG
    Fiziol Zh SSSR Im I M Sechenova; 1977 Mar; 63(3):429-33. PubMed ID: 301104
    [No Abstract]   [Full Text] [Related]  

  • 49. Inflammatory changes in tumour vessels after systemic 5-hydroxytryptamine, bradykinin, kallikrein, or lysolecithin.
    Cater DB; Taylor CR
    Br J Cancer; 1966 Sep; 20(3):517-25. PubMed ID: 4288477
    [No Abstract]   [Full Text] [Related]  

  • 50. Kallikrein-kinin system in the angiogenesis.
    Ferreira MA; Andrade SP; Pesquero JL; Feitosa MH; Oliveira GM; Rogana E; Nogueira JC; Beraldo WT
    Agents Actions Suppl; 1992; 38 ( Pt 2)():165-74. PubMed ID: 1281370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat.
    Wang C; Ford P; Chao C; Chao L; Chao J
    Am J Physiol; 1997 Nov; 273(5):F783-9. PubMed ID: 9374842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The bronchoconstrictor action of bradykinin in the guinea-pig.
    COLLIER HO; HOLGATE JA; SCHACHTER M; SHORLEY PG
    Br J Pharmacol Chemother; 1960 Jun; 15(2):290-7. PubMed ID: 13811230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A spectrum of pharmacological activity in some biologically active peptides.
    BISSET GW; LEWIS GP
    Br J Pharmacol Chemother; 1962 Aug; 19(1):168-82. PubMed ID: 13869527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kallistatin is a potent new vasodilator.
    Chao J; Stallone JN; Liang YM; Chen LM; Wang DZ; Chao L
    J Clin Invest; 1997 Jul; 100(1):11-7. PubMed ID: 9202051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Visceral receptors concerned in visceral pain and the pseudaffective response to intra-arterial injection of bradykinin and other algesic agents.
    LIM RK; LIU CN; GUZMAN F; BRAUN C
    J Comp Neurol; 1962 Jun; 118():269-93. PubMed ID: 14465294
    [No Abstract]   [Full Text] [Related]  

  • 56. Biological activity of synthetic polypeptides with bradykinin-like properties.
    KONZETT H; STURMER E
    Br J Pharmacol Chemother; 1960 Dec; 15(4):544-51. PubMed ID: 13753032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of renal kallikrein in the regulation of bicarbonate excretion in rats.
    Marin-Grez M; Vallés P; Odigie PI
    J Physiol; 1995 Oct; 488 ( Pt 1)(Pt 1):163-70. PubMed ID: 8568652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats.
    Chao C; Madeddu P; Wang C; Liang Y; Chao L; Chao J
    Am J Physiol; 1996 Jul; 271(1 Pt 2):F78-86. PubMed ID: 8760246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kallikrein-induced uterine contraction independent of kinin formation.
    Chao J; Buse J; Shimamoto K; Margolius HS
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6154-7. PubMed ID: 6947218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activity and functional significance of the renal kallikrein-kinin-system in polycystic kidney disease of the rat.
    Braun C; Kleemann T; Hilgenfeldt U; Riester U; Rohmeiss P; van der Woude FJ
    Kidney Int; 2002 Jun; 61(6):2149-56. PubMed ID: 12028455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.